Insider Trading History of Bratton Capital Inc.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bratton Capital Inc. since 2018. The trader's CIK number is 1723783. At the time of the last reporting, Bratton Capital Inc. was the 10% Owner of Denali Therapeutics Inc.. (stock ticker symbol DNLI). Also see all insider trading activities at Denali Therapeutics Inc..

Note that in the past Bratton Capital Inc. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Denali Therapeutics Inc. (DNLI) by Bratton Capital Inc.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 DNLI 0 $0 569,624 $17,564,225 0 $0

Yearly summary of insider trading at Aquestive Therapeutics, Inc. (AQST) by Bratton Capital Inc.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 AQST 165,000 $2,475,000 0 $0 0 $0


Insider trading activities at 2 companies by Bratton Capital Inc.:

1. Denali Therapeutics Inc. (DNLI)

2. Aquestive Therapeutics, Inc. (AQST)

Table 1. Insider trading of Denali Therapeutics Inc. (DNLI) by Bratton Capital Inc.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-14 DNLI Sale 17,825 80.74 1,439,137
2020-12-11 DNLI Sale 46,799 80.05 3,746,447
2020-06-30 DNLI Sale 45,345 24.17 1,096,124
2020-06-29 DNLI Sale 82,578 24.17 1,995,992
2020-06-26 DNLI Sale 122,077 24.26 2,961,343
2020-06-19 DNLI Sale 144,920 24.60 3,564,597
2020-06-23 DNLI Sale 20,024 25.94 519,362
2020-06-22 DNLI Sale 90,056 24.89 2,241,223

Table 2. Insider trading of Aquestive Therapeutics, Inc. (AQST) by Bratton Capital Inc.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-24 AQST Buy 165,000 15.00 2,475,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bratton Capital Inc. (10% Owner of Denali Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.